Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis
Katsuhiko Nara(University of Tokyo Hospital), Tappei Takada(University of Tokyo Hospital), Yukari Uemura(University of Tokyo Hospital), Sebastiano Buti(University of Parma), Satoru Taguchi(Iwate Medical University), Takehito Yamamoto(University of Tokyo Hospital), Haruki Kume(The University of Tokyo), Taketo Kawai(National Center for Global Health and Medicine)
Cited by 13
Related Papers
Decreased extra-renal urate excretion is a common cause of hyperuricemia
|Nature Communications|2012|703
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|438
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
|Clinical Cancer Research|2019|240
Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes
|Annals of the Rheumatic Diseases|2015|185
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes
|Annals of the Rheumatic Diseases|2016|177